Richard Kender
Vermögen: 106 162 $ am 31.05.2026
Vermögen: 106 162 $ am 31.05.2026
Richard N.
Kender is Executive Chairman & Chief Executive Officer at Seres Therapeutics, Inc. since 2026.
He is a Director at Abide Therapeutics, Inc., BicycleTx Ltd. since 2019, and Bicycle Therapeutics, Inc. Former roles include Director at Inspire Pharmaceuticals, Inc., FoxHollow Technologies, Inc. (2006-2007), ev3, Inc. (2007-2008), Abide Therapeutics, Inc. (2015-2019), Syneos Health NC LLC, BioNJ, Inc., Omega Therapeutics, Inc., Poxel SA, and Independent Director at INC Research Holdings, Inc. (2014-2017), Longeveron, Inc. (2024-2026).
Served as Independent Non-Executive Director at Bicycle Therapeutics Plc (2019-2025) and Non-Executive Director at ReViral Ltd. (2019-2022).
Worked at Merck & Co., Inc. from 1978 to 2013, including as SVP-Business Development & Corporate Licensing (2000-2013).
Education includes an MBA from Fairleigh Dickinson University and undergraduate studies at Villanova University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.04.2026 | 12.250 ( 0,03 % ) | 57 453 $ | 31.05.2026 | |
LONGEVERON INC. CLASS A 0,11 % | 15.07.2025 | 33.000 ( 0,11 % ) | 25 476 $ | 31.05.2026 |
SERES THERAPEUTICS INC 0,03 % | 13.04.2026 | 3.174 ( 0,03 % ) | 23 234 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SERES THERAPEUTICS, INC. | Vorstandsvorsitzender | 02.03.2026 |
Bicycle Therapeutics, Inc.
Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines and therapeutics for cancer treatment | Direktor/Vorstandsmitglied | - |
BicycleTx Ltd.
BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Direktor/Vorstandsmitglied | 12.08.2019 |
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| LONGEVERON INC. | Direktor/Vorstandsmitglied | 04.03.2026 |
| BICYCLE THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 17.06.2025 |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Direktor/Vorstandsmitglied | 01.06.2022 |
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Direktor/Vorstandsmitglied | 01.01.2019 |
INC Research Holdings, Inc.
INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interests in clinical research | Direktor/Vorstandsmitglied | 01.08.2017 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 18 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Health Technology |
FoxHollow Technologies, Inc.
FoxHollow Technologies, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures, and sells medical devices for the treatment of peripheral artery disease | Health Technology |
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and distributes medical devices | Health Technology |
Poxel SA
Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Health Technology |
Syneos Health NC LLC
Syneos Health NC LLC Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Bicycle Therapeutics Plc
Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
INC Research Holdings, Inc.
INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interests in clinical research | Commercial Services |
Seres Therapeutics, Inc.
Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Health Technology |
Longeveron, Inc.
Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
Omega Therapeutics, Inc.
Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
BicycleTx Ltd.
BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
Bicycle Therapeutics, Inc.
Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines and therapeutics for cancer treatment | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen